课题基金 / 基金详情

Characterization of actin-targeting compounds intended for use as cancer metastasis inhibitors

Characterization of actin-targeting compounds intended for use as cancer metastasis inhibitors
用作癌症转移抑制剂的肌动蛋白靶向化合物的表征
批准号：
367272
负责人：
Nersesian Sarah
金额：
$1.27万
依托单位：
Queen's University (Kingston, Ontario)
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-12-01 至 2017-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=367272&lang=en
关键词：
Actin Cytoskeleton In Cancer Metastasis Actin Toxins Actin-Targeting Compounds Antibody-Drug Conjugate Cancer Metastasis Targeted Cancer Therapies

项目摘要

项目成果

Nersesian Sarah的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cancer metastasis is a process by which cancer cells spread from primary tumors to other tissues is responsible for 90% of cancer related deaths. These high mortality rates speak to the urgent need to improve therapies that prevent metastasis. Metastatic
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The prognostic value of NK cell infiltration, localization and phenotype in high grade serous ovarian carcinoma
  • 批准号：
    439555
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $7.65万
  • 财政年份：
    2020
  • 负责人：
    Nersesian Sarah
  • 依托单位：
    Dalhousie University (Nova Scotia)
The prognostic value of NK cell infiltration, localization and phenotype in high grade serous ovarian carcinoma
  • 批准号：
    437215
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $10.93万
  • 财政年份：
    2020
  • 负责人：
    Nersesian Sarah
  • 依托单位：
    Dalhousie University (Nova Scotia)